Treatment outcomes of intracranial germinoma: a retrospective analysis of 170 patients from a single institution.
Xin LianXiaorong HouJunfang YanShuai SunZheng MiaoZhikai LiuWeiping WangJing ShenJie ShenKe HuFu-Quan ZhangPublished in: Journal of cancer research and clinical oncology (2018)
WVI or WBRT+ primary boost (PB) is a sufficient irradiation field for localized intracranial germinoma, while patients with bifocal disease should undergo craniospinal irradiation (CSI), especially when treated with RT alone. CSF β-HCG is not a prognostic marker for intracranial germinomas. The treatment results of chemotherapy followed by reduced-dose RT are comparable to those of RT alone. IMRT is recommended for intracranial germinoma to improve the target volume accuracy and decrease the complications of RT.